<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1684-1824</journal-id>
<journal-title><![CDATA[Revista Médica Electrónica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Med.Electrón.]]></abbrev-journal-title>
<issn>1684-1824</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Matanzas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1684-18242024000100037</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Estudio de las trombofilias por el laboratorio clínico]]></article-title>
<article-title xml:lang="en"><![CDATA[Study of thrombophilia by the clinical laboratory]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Suárez-González]]></surname>
<given-names><![CDATA[Adalberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Linares-Morera]]></surname>
<given-names><![CDATA[Anmy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Rodríguez]]></surname>
<given-names><![CDATA[Maylan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>46</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1684-18242024000100037&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1684-18242024000100037&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1684-18242024000100037&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN La trombofilia se define como una predisposición individual a padecer episodios tromboembólicos. Debido a la elevada y creciente incidencia tanto mundial como en Cuba de eventos cardiovasculares, cerebrovasculares y vasculares periféricos, cuya patogenia involucra la trombofilia, se hace necesaria una actualización de la utilidad de las pruebas de laboratorio clínico para su estudio. Esta revisión tiene como objetivo actualizar la información sobre la indicación e interpretación de los exámenes de laboratorio clínico útiles en el estudio de las trombofilias. Se realizaron búsquedas en las bases de datos PubMed, SciELO, LILACS y ClinicalKey, con las palabras clave &#8220;trombofilia&#8221; y &#8220;laboratorio clínico&#8221;, en inglés y español. La búsqueda reveló 120 artículos, de los cuales 27 fueron novedosos y relevantes para el tema. Se debe investigar el estado trombofílico en cualquier paciente que presente trombosis venosa antes de los 45 años -recurrente o en sitios inusuales-, trombosis neonatal inexplicable, necrosis cutánea por cumarínicos, resistencia a anticoagulantes, trombosis arterial antes de los 30 años, historia familiar trombofílica, pérdida recurrente de embarazos, púrpura trombocitopénica trombótica o lupus eritematoso sistémico. Las investigaciones iniciales serán: hemograma completo, observación de extensión coloreada de sangre periférica y tiempo parcial de tromboplastina activada. Los exámenes más específicos incluirán el estudio genético del factor V Leiden, ensayos para detectar déficits de antitrombina, proteína C o proteína S; análisis del ADN para el alelo G20210A de la protrombina, determinación del factor VIII y de homocisteína, y detección de anticoagulante lúpico, anticuerpos anti-&#946;2-glicoproteína I y anticardiolipina.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Thrombophilia is defined as an individual predisposition to suffer thromboembolic episodes. Due to high and growing incidence both worldwide and in Cuba of cardiovascular, cerebrovascular and peripheral vascular events whose pathogenesis involves thrombophilia, it becomes necessary an update of the usefulness of clinical laboratory tests used for their study. The review aims to update information on indication and interpretation of clinical laboratory tests useful in the study of thrombophilia. Searches were carried out in the databases PubMed, SciELO, LILACS and ClinicalKey with key words thrombophilia and clinical laboratory, in English and Spanish, the search reveled 120 articles, of which 27 were novel and relevant to the topic. Thrombophilic status should be investigated in any patient who presents venous thrombosis before the age of 45-recurrent or in unusual sites-unexplained neonatal thrombosis, coumarin skin necrosis, resistance to anticoagulant, arterial thrombosis before the age of 30, thrombophilic familiar history, recurrent pregnancy loss, thrombotic thrombocytopenic purpura or systemic lupus erythematosus. Initial tests should be: complete blood count, observation of colored smear of peripheral blood, and activated partial of thromboplastin time. More specific tests will include the genetic study of factor V Leiden, tests to detect antithrombin, protein C or protein S deficiencies; DNA analysis for the G20210A allele of prothrombin, factor VIII and homocysteine measurement, and detection of lupus anticoagulant, anti-&#946;2-glycoprotein I and anticardiolipin antibodies.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[trombofilia]]></kwd>
<kwd lng="es"><![CDATA[laboratorio clínico]]></kwd>
<kwd lng="en"><![CDATA[thrombophilia]]></kwd>
<kwd lng="en"><![CDATA[clinical laboratory]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cruz-García]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Nieto-Monteagudo]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Hurtado]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trombosis venosa profunda y trombofilia congénita]]></article-title>
<source><![CDATA[Rev Cubana Anestesiol Reanim]]></source>
<year>2021</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gill]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dhull]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bhardwaj]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of inherited procoagulant states in cerebral venous thrombosis and its correlation with severity and outcome]]></article-title>
<source><![CDATA[Neurosci Rural Pract]]></source>
<year>2022</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-72</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tauqeer]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Bracha]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[McGeehan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypercoagulability testing and hypercoagulable disorders in young central retinal vein occlusion patients]]></article-title>
<source><![CDATA[Ophthalmol Retina]]></source>
<year>2022</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>37-42</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olivo Freites]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Naymagon]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The utility of hereditary thrombophilia testing among patients with unprovoked venous thromboembolism]]></article-title>
<source><![CDATA[Int J Lab Hematol]]></source>
<year>2022</year>
<volume>44</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>393-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lobo]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2022</year>
<volume>58</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>246-54</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Prats-Uribe]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19]]></article-title>
<source><![CDATA[JAMA Intern Med]]></source>
<year>2022</year>
<volume>182</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1063-70</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[MdJ]]></surname>
<given-names><![CDATA[Bustillo-Santandreu]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-López]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Feíto-Castex]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Morbi-mortalidad de la enfermedad tromboembólica venosa en el Hospital Universitario &#8220;Arnaldo Milián Castro&#8221;]]></article-title>
<source><![CDATA[Rev Cubana Angiol Cir Vasc]]></source>
<year>2022</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arachchillage]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mackillop]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chandratheva]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombophilia testing: A British Society for Haematology guideline]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2022</year>
<volume>198</volume>
<page-range>443-58</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Sacerio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Iribar]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz-Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad tromboembólica venosa en hemopatías malignas: un enfoque desde la prevención]]></article-title>
<source><![CDATA[Rev Cubana Hematol Immunol Hemoter]]></source>
<year>2022</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tefferi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Barbui]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management]]></article-title>
<source><![CDATA[Am J Hematol]]></source>
<year>2020</year>
<volume>95</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1599-613</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Asakrah]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bhargava]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Practical considerations and testing nuances for the detection of lupus anticoagulant: Do low phospholipid screen results, assay type, and test ratio matter?]]></article-title>
<source><![CDATA[Am J Clin Pathol]]></source>
<year>2021</year>
<volume>156</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1073-82</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Gu]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction]]></article-title>
<source><![CDATA[J Thromb Thrombolysis]]></source>
<year>2022</year>
<volume>54</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>318-22</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abughanimeh]]></surname>
<given-names><![CDATA[OK]]></given-names>
</name>
<name>
<surname><![CDATA[Marar]]></surname>
<given-names><![CDATA[RI]]></given-names>
</name>
<name>
<surname><![CDATA[Tahboub]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hereditary thrombophilia testing among hospitalized patients: Is it warranted?]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2022</year>
<volume>14</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takhviji]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Zibara]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Maleki]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism]]></article-title>
<source><![CDATA[Thromb J]]></source>
<year>2021</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>74</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wei]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[He]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical phenotype and genetic analysis of twins with congenital coagulation factor V deficiency]]></article-title>
<source><![CDATA[J Pediatr Hematol Oncol]]></source>
<year>2022</year>
<volume>44</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ardizzone]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Capra]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Mondello]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[H1299R variant in Factor V and recurrent pregnancy loss: A systematic review and meta-analysis protocol]]></article-title>
<source><![CDATA[Genes (Basel)]]></source>
<year>2022</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1019</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cepero Llauger]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Rosales]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Carnot Uria]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Caracterización de la trombofilia en pacientes con mutación del factor V de Leiden en el Hospital Hermanos Ameijeiras 2011-2021]]></source>
<year>2022</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Convención Científica XL Aniversario Hospital Hermanos Ameijeiras]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Noiri]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Matsuzoe]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nagaya]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A case of venous thromboembolism caused by protein C deficiency due to a novel gene mutation]]></article-title>
<source><![CDATA[J Cardiol Cases]]></source>
<year>2022</year>
<volume>26</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>360-3</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brouns]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Tullemans]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Bulato]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow]]></article-title>
<source><![CDATA[Res Pract Thromb Haemost]]></source>
<year>2022</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kashfi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Farhan Nasser]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soleiman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clot in transit in a patient with protein S deficiency]]></article-title>
<source><![CDATA[Eur J Case Rep Intern Med]]></source>
<year>2022</year>
<volume>9</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zamora González]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Urrutia Febles]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Forrellat Barrios]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trombosis y su relación con la deficiencia de proteínas C y S]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></source>
<year>2020</year>
<volume>36</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kruijt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Van der Pol]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Eikenboom]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unraveling a borderline antithrombin deficiency case with quantitative mass spectrometry]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2022</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>145-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Raptopoulou]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Michou]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Mourtzi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Large-scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population]]></article-title>
<source><![CDATA[Health Sci Rep]]></source>
<year>2022</year>
<volume>5</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Phair]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Naymagon]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utility of hereditary thrombophilia testing among patients with lower extremity deep vein thrombosis]]></article-title>
<source><![CDATA[J Vasc Surg Venous Lymphat Disord]]></source>
<year>2022</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>841-5</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khalife]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Geitani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of inherited thrombophilia with recurrent pregnancy loss in a population of Lebanese women: A Case Control Study]]></article-title>
<source><![CDATA[Int J Fertil Steril]]></source>
<year>2022</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>247-51</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tamayo-Velasco]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cebeira]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bombín-Canal]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fibrinogen deficiency with thrombotic manifestations]]></article-title>
<source><![CDATA[Eur J Case Rep Intern Med]]></source>
<year>2022</year>
<volume>9</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deloughery]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[WTD Steering Committee. A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing]]></article-title>
<source><![CDATA[Res Pract Thromb Haemost]]></source>
<year>2022</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
